Search Results
Feb 12, 2026, 15:30 ET LA COMMISSION EUROPEENNE APPROUVE UPLIZNA® D'AMGEN DANS LE CADRE DU TRAITEMENT DE LA MYASTHÉNIE GRAVE GÉNÉRALISÉE
par rapport aux valeurs initiales du score MG-ADL à la semaine 26 pour la cohorte AChR+ et séparément la cohorte MuSK+ ; et le changement par rapport aux valeurs initiales du score QMG à la semaine 26 pour la cohorte AChR+ et séparément la cohorte MuSK+.5 MINT comprend également une période
More news about: Amgen
Feb 12, 2026, 15:15 ET La Comisión Europea aprueba UPLIZNA® de Amgen para la miastenia gravis generalizada
cambio desde el valor inicial en la puntuación MG-ADL en la semana 26 para la cohorte AChR+ y por separado la cohorte MuSK+; y el cambio desde el valor inicial en la puntuación QMG en la semana 26 para la cohorte AChR+ y por separado la cohorte MuSK+.5 MINT también incluye un período de tratamiento
More news about: Amgen
Feb 12, 2026, 10:28 ET Record Defense AI Spending Opens a Procurement Window
VisionWave Holdings Inc. (NASDAQ: VWAV), Lockheed Martin (NYSE: LMT), Northrop Grumman (NYSE: NOC), Archer Aviation (NYSE: ACHR), and Woodward (NASDAQ: WWD) are building the perception, training, and control systems at the center of this procurement cycle.
More news about: USA News Group
Feb 12, 2026, 09:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS
people with anti‑AChR and anti‑MuSK antibody positive gMG, UPLIZNA brings a new first-in-class approach to managing this complex disease."The EC approval is supported by data from the Myasthenia Gravis Inebilizumab Trial (MINT), the largest Phase 3 biologic study to include both AChR+ and MuSK+ patients,
More news about: Amgen
Feb 03, 2026, 16:01 ET AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
and Drug Administration (FDA) approved UPLIZNA for the treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) and anti-muscle specific tyrosine kinase (MuSK) antibody positive.The Company expects to initiate Phase 3 studies of UPLIZNA in patients with
More news about: Amgen
Dec 19, 2025, 09:41 ET Heather Ripley launches updated "Next Level Now" book for home services
Celebrity Apprentice. She has received numerous accolades related to her work in home services PR, including the PRNews Top Women Award for 2024. ACHR News chose her as one of the Top Women in HVAC, also in 2024.Since 2013, Ripley PR has been the leading name in public relations for the home
More news about: Ripley PR
Dec 18, 2025, 11:27 ET Drones as a Service (DaaS) Delivering Future-Ready Drone Operations for Today's Military and Defense Services
Inc. (NASDAQ: ONDS), AgEagle Aerial Systems Inc. (NYSE: UAVS), AIRO Group Holdings (NASDAQ: AIRO), Archer Aviation (NYSE: ACHR). Mordor Intelligence continued: "Training and simulation grew fastest at a 24.41% CAGR as labor shortfalls increased demand for scenario-based
More news about: Market News Updates
Dec 11, 2025, 18:09 ET FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
placebo had reduced their steroid dose to 5 mg or less per day.6 "UPLIZNA showed strong efficacy at 26 weeks in both AChR+ and MuSK+ patients, with AChR+ patients continuing to improve through 52 weeks in MINT," said Richard J. Nowak, M.D., M.S., global principal investigator and director
More news about: Amgen
Nov 20, 2025, 07:02 ET Lemon Seed rolls out the red carpet for home service marketing at its 2026 conference
Upskilled Consulting and is a learning and development expert specializing in technician training and onboarding for the home service industry. A former ACHR NEWS "40 Under 40" honoree, she helps companies build scalable, high-impact training systems. Shanna
More news about: Lemon Seed Marketing
Oct 30, 2025, 07:02 ET Women in HVACR celebrates new president, award winners at its Bet on Yourself conference
ACHR News' Top Women in HVAC; and a range of workshops and after-hour networking events. For more information about Women in HVACR,
More news about: Women in HVACR
Oct 29, 2025, 08:05 ET Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting
approved by the U.S. Food and Drug Administration for adult and pediatric patients (12 years of age and older) with anti-AChR or anti-MuSK antibody positive gMG, in Brazil by ANVISA for anti-AChR, anti-MuSK or anti-LRP4 antibody positive adults and pediatric patients aged 12 and older and in Japan by the Pharmaceuticals
More news about: Johnson & Johnson
Oct 29, 2025, 07:00 ET UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
In June 2023, rozanolixizumab-noli was approved by the FDA, for the treatment of gMG in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody-positive, having been granted Priority Review for its Biologic License Application (BLA).13
More news about: UCB
Oct 24, 2025, 18:32 ET Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies
approved by the U.S. Food and Drug Administration for adult and pediatric patients (12 years of age and older) with AChR or MuSK antibody positive gMG, in Brazil by ANVISA for anti-AChR, anti-MuSK or anti-LRP4 antibody positive adults and pediatric patients aged 12 and older, and in Japan by the Pharmaceuticals
More news about: Johnson & Johnson
Oct 22, 2025, 08:30 ET Archer Named Exclusive Air Taxi Partner For The Los Angeles Sports & Entertainment Commission, Will Serve As Official Los Angeles World Cup 2026 Host City Supporter And Official Partner For The Super Bowl LXI Host Committee
Oct. 22, 2025 /PRNewswire/ -- The Los Angeles Sports & Entertainment Commission (LASEC) today announced Archer (NYSE: ACHR) as its exclusive Air Taxi Partner. As part of this designation, Archer will serve as an Official Los Angeles World Cup 2026 Host City Supporter and
More news about: Archer Aviation & LASEC
Oct 22, 2025, 07:01 ET Ripley PR founder and CEO Heather Ripley to present at PHCC CONNECT 2025
and reputation. Her expertise in home services PR has earned her numerous accolades, including the PRNews Top Women Award (2024) and recognition by ACHR News as one of the Top Women in HVAC (2024). She is also the author of "NEXT LEVEL NOW: PR Secrets to Drive Explosive Growth for your Home Service Business,"
More news about: Ripley PR
Oct 02, 2025, 10:30 ET Defense Tech Grows as AI Security Threats Push $28B Investment Wave
Holdings Inc. (NASDAQ: VWAV), NUBURU, Inc. (NYSE-American: BURU), VirTra, Inc. (NASDAQ: VTSI), Archer Aviation Inc. (NYSE: ACHR), and WidePoint Corporation (NYSE-American: WYY) to benefit from market opportunities, subject to various risks and uncertainties.
More news about: USA News Group
Sep 17, 2025, 21:00 ET Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting
affect mobility, vision, swallowing, and breathing. The disease is antibody-mediated, primarily by autoantibodies against the acetylcholine receptor (AChR) or muscle-specific kinase (MuSK), which interfere with neuromuscular transmission. Despite various treatment options, many patients continue to suffer
More news about: RemeGen Co., Ltd
Sep 15, 2025, 08:45 ET 3D & 4D Military Radars Market Expects Substantial Growth To $17 Billion By 2033 Influenced by AI Driven Technology
(NYSE: TXT), L3Harris Technologies (NYSE: LHX), Archer Aviation Inc. (NYSE: ACHR), Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS).
More news about: MarketNewsUpdates